IMMUNEERING
Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying its deep knowledge of translational bioinformatics to every stage of the drug development process. It has more than a decade of experience in translational bioinformatics and generating insights into drug mechanisms of action and patient treatment responses.
IMMUNEERING
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2008-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.immuneering.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 500 8080
Total Funding:
57.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
AnaBios
AnaBios provides contract research services for biotechnology and pharmaceutical industries.
Cypris
Cypris is a market intelligence dashboard & patent search engine built for research and development & intellectual property teams.
GeneCentrix, Inc.
GeneCentrix is a big-data bioinformatics company developing software tools for early-stage drug discovery.
KalGene Pharmaceuticals
KalGene Pharmaceuticals is a biotech company that develops precision medicine therapeutics for patients suffering from Alzheimer's disease.
Aquestive Therapeutics
Aquestive is a specialty pharmaceutical company that advances and commercializes medicines to solve critical healthcare problems.
NMD Pharma
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
NovAliX
NovAliX is a company that aids managers, scientists, and project managers with drug discovery projects.
PaxVax
PaxVax is a start-up developing candidate oral vaccines for key infectious diseases.
Protégé Biomedical
Protégé Biomedical is a company with a unique new line of hemostatic products developed to stop bleeding in animals and humans*.
Regor Therapeutics
Regor Therapeutics is an international biotech company that focuses in the therapeutic areas of oncology, metabolic and autoimmune diseases.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Truwl
Truwl is a bioinformatics company that engages in accelerating and simplifying biological research.
Current Advisors List
Board_member
Board_member
2022-01-01
Board_member
Advisor
2014-10-01
Current Employees Featured
Ben Zeskind Co-Founder and CEO @ Immuneering
Co-Founder and CEO
2008-01-01
Carolina Garcia-Rizo Chief Business Officer @ Immuneering
Chief Business Officer
2021-01-01
Founder
Stock Details
Investors List
Ion Pacific
Ion Pacific investment in Post-IPO Equity - Immuneering
Boxcar Capital Partners
Boxcar Capital Partners investment in Series A - Immuneering
Official Site Inspections
http://www.immuneering.com Semrush global rank: 5.14 M Semrush visits lastest month: 1.58 K
- Host name: 93.75.197.35.bc.googleusercontent.com
- IP address: 35.197.75.93
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Immuneering"
Immuneering Corporation
Immuneering helps leading pharmaceutical companies use genetic, genomic, and proteomic data to generate biological insights that enhance the clinical and commercial success of medicines. …See details»
Contact Us - Immuneering Corporation
Ebrakewood@immuneering.com. Harold “E.B.” Brakewood. Locations: Boston. 245 Main St, 2nd Floor Cambridge, MA 02142. New York. 667 Madison Ave New York, NY 10065. ... we are a vibrant organization shaped by the challenges …See details»
Immuneering Corporation
Immuneering helps pharmaceutical companies use genetic, genomic, and proteomic data to generate biological insights that enhance the success of medicines.See details»
Immuneering - Crunchbase Company Profile & Funding
Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by …See details»
Meet The Team - Immuneering Corporation
Ms. Flannery joined Immuneering’s clinical team in October 2022. Prior to joining Immuneering, she held a variety of clinical positions in the pediatrics and dermatology fields before joining a clinical research organization as Lead …See details»
Immuneering Corporation - LinkedIn
Immuneering Corporation | 2,671 followers on LinkedIn. Better Medicines Through Signaling Dynamics | Immuneering is a biopharmaceutical company with an emerging pipeline focused on improving ...See details»
Immuneering Corporation Information - RocketReach
Immuneering has more than a decade of experience in translational bioinformatics and generating insights into drug mechanisms of action and patient treatment responses. Building on this …See details»
Immuneering - Overview, News & Similar companies - ZoomInfo
Immuneering to Present at the Jefferies Healthcare Conference CAMBRIDGE, Mass., May 30, 2023 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage …See details»
Immuneering Company Profile 2025: Stock …
Immuneering General Information Description. Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep …See details»
Immuneering - Funding, Financials, Valuation & Investors
Immuneering is registered under the ticker NASDAQ:IMRX . Their stock opened with $15.00 in its Jul 30, 2021 IPO. Stock Symbol NASDAQ:IMRX ; Valuation at IPO $365.8M; Money Raised at …See details»
Immuneering Company Profile - Office Locations, Competitors
Immuneering is a biopharmaceutical company that develops medicines for the treatment of a spectrum of oncologic diseases. Its pipeline includes IMM-1-104 that aims to achieve universal …See details»
Immuneering - Contacts, Employees, Board Members, Advisors
Organization. Immuneering . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Immuneering has 3 current employee profiles, including Co-Founder and …See details»
Drug Development - Immuneering Corporation
More than nine million people die of cancer every year, demonstrating the urgent need to develop new medicines for patients in need. Yet traditional drug discovery is deeply inefficient. Drug …See details»
Immuneering Provides Positive Update on Phase 2a Arm Studying …
1 day ago Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The …See details»
Immuneering Announces Positive Data Update from Three …
Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The Company’s lead product …See details»
Immuneering to Present Data from Three Arms of its Ongoing …
CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize universal …See details»
Immuneering Appoints Biren Amin, M.B.A., as Chief Financial Officer
Apr 6, 2021 Immuneering’s novel drug candidates spare healthy normal cells by modulating signaling dynamics to focus therapeutic impact against tumor cells. Immuneering’s platform …See details»
Immuneering announces update from its Phase 2a arm studying …
1 day ago Immuneering announced a positive update from its Phase 2a arm studying IMM-1-104 in combination with modified FOLFIRINOX in first-line pancreatic cancer, and provided a …See details»
Immuneering Gets Encouraging Data From Ongoing IMM-1-104 …
6 days ago (RTTNews) - Immuneering Corp. (IMRX), Tuesday announced positive data update from three arms of its ongoing Phase 2a trial of lead program IMM-1-104 for the treatment of …See details»
Immuneering Provides Positive Update on Phase 2a Arm
19 hours ago Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The …See details»